Several molecular driver mutations have been identified within NSCLC including mutation of epidermal growth factor receptor (EGFR), as well as fusion of anaplastic lymphoma kinase (ALK) and echinoderm microtubule-associated protein-like 4 (EML4) genes [1]. This evidence concerns the gene ALK and non-small cell lung carcinoma.